Calidi Biotherapeutics Patents – Insights & Stats (Updated 2024)

Calidi Biotherapeutics has a total of 62 patents globally, out of which 28 have been granted. Of these 62 patents, more than 91% patents are active. The United States of America is where Calidi Biotherapeutics has filed the maximum number of patents, followed by Japan and Canada. Parallelly, United States of America seems to be the main focused R&D centre and also is the origin country of Calidi Biotherapeutics.

Calidi Biotherapeutics was founded in 2014. Calidi Biotherapeutics is a company that creates advanced treatments for cancer. Their therapies target solid tumors and train the immune system to find and destroy cancer cells in the body.

Do read about some of the most popular patents of Calidi Biotherapeutics which have been covered by us in this article and also you can find Calidi Biotherapeutics patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Calidi Biotherapeutics patent portfolio.

How many patents does Calidi Biotherapeutics have?

Calidi Biotherapeutics has a total of 62 patents globally. These patents belong to 5 unique patent families. Out of 62 patents, 57 patents are active.

How Many Patents did Calidi Biotherapeutics File Every Year?

Calidi Biotherapeutics Patent Filing Trend

Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.

Year of Patents Filing or GrantCalidi Biotherapeutics Applications FiledCalidi Biotherapeutics Patents Granted
202347
202236
202123
2020211
201922
201831
20173
201610
201513

How many Calidi Biotherapeutics patents are Alive/Dead?

Worldwide Patents

Calidi Biotherapeutics Patent Portfolio

How Many Patents did Calidi Biotherapeutics File in Different Countries?

Calidi Biotherapeutics Worldwide Patent Filing

Countries in which Calidi Biotherapeutics Filed Patents

CountryPatent
United States Of America10
Japan6
Canada6
China4
Europe4
Mexico3
South Korea3
Hong Kong (S.A.R.)3
Eurasian Patent Organization3
Australia3
Italy2
Singapore2
Germany2
Russia1
South Africa1
Israel1
India1
Brazil1
Spain1
Austria1
New Zealand1
Indonesia1

Where are Research Centers of Calidi Biotherapeutics Patents Located?

The Research Centers of Calidi Biotherapeutics Patents is the United States of America.

What Percentage of Calidi Biotherapeutics US Patent Applications Were Granted?

Calidi Biotherapeutics (Excluding its subsidiaries) has filed 8 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these 6 have been granted leading to a grant rate of 100%.

Below are the key stats of Calidi Biotherapeutics patent prosecution at the USPTO.

Which Law Firms Filed Most US Patents for Calidi Biotherapeutics?

Law FirmTotal ApplicationsSuccess Rate
Lkglobal6100%

What are Calidi Biotherapeutics key innovation segments?

What Technologies are Covered by Calidi Biotherapeutics?

The chart below distributes patents filed by Calidi Biotherapeutics in different countries on the basis of the technology protected in patents. It also represents the markets where Calidi Biotherapeutics thinks it’s important to protect particular technology inventions.

R&D Focus: How has Calidi Biotherapeutics search focus changed over the years?

EXCLUSIVE INSIGHTS COMING SOON!

Interested in knowing about the areas of innovation that are being protected by Calidi Biotherapeutics?

Related Articles

5ire Patents – Insights & Stats (Updated 2024)

5ire has a total of 7 patents globally, out of which no patent has been granted. Of these 7 patents, more than 14% patents are active. The United States of America and United Kingdom is where 5ire has filed the maximum number of patents, followed by Europe (EPO). Parallelly, United

Read More »

Abogen Patents – Insights & Stats (Updated 2024)

Abogen has a total of 25 patents globally, out of which 10 have been granted. Of these 25 patents, more than 48% patents are active. Japan is where Abogen has filed the maximum number of patents, followed by Europe (EPO). Parallelly, Europe (EPO) seems to be the main focused R&D

Read More »

Leave a Comment

Fill the form to get the details:

Fill the form to get the details:

Our comprehensive report provides an in-depth look into the patent portfolio. The report includes a breakdown of the patent portfolio across various technologies, listing the patent along with brief summaries of each patent's technology.